S'abonner

Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: Findings from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status registry - 16/11/11

Doi : 10.1016/j.ahj.2011.08.005 
S. Michael Gharacholou, MD a, , Kimberly J. Reid, MS b, Suzanne V. Arnold, MD, MHA b, John Spertus, MD, MPH b, Michael W. Rich, MD c, Patricia A. Pellikka, MD a, Mandeep Singh, MD a, Tracey Holsinger, MD d, Harlan M. Krumholz, MD, SM e, Eric D. Peterson, MD, MPH f, Karen P. Alexander, MD f
a Mayo Clinic, Rochester, MN 
b University of Missouri and St Luke's Mid America Heart Institute, Kansas City, MO 
c Washington University, St Louis, MO 
d Durham Veterans Affairs Medical Center and Duke University Medical Center, Durham, NC 
e Yale University School of Medicine, New Haven, CT 
f Duke Clinical Research Institute, Durham, NC 

Reprint requests: S. Michael Gharacholou, MD, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, MC 3248 H6/319 CSC, Madison, WI 53792-3248.

Résumé

Background

Cognitive impairment without dementia (CIND) and acute myocardial infarction (AMI) are prevalent in older adults; however, the association of CIND with outcomes after AMI is unknown.

Methods

We used a multicenter registry to study 772 patients ≥65 years with AMI, enrolled between April 2005 and December 2008, who underwent cognitive function assessment with the Telephone Interview for Cognitive Status-modified (TICS-m) 1 month after AMI. Patients were categorized by cognitive status to describe characteristics and in-hospital treatment, including quality of life and survival 1 year after AMI.

Results

Mean age was 73.2 ± 6.3 years; 58.5% were men, and 78.2% were white. Normal cognitive function (TICS-m >22) was present in 44.4%; mild CIND (TICS-m 19-22) in 29.8%; and moderate/severe CIND (TICS-m <19) in 25.8% of patients. Rates of hypertension (72.6%, 77.4%, and 81.9%), cerebrovascular accidents (3.5%, 7.0%, and 9.0%), and myocardial infarction (20.1%, 22.2%, and 29.6%) were higher in those with lower TICS-m scores (P < .05 for comparisons). AMI medications were similar by cognitive status; however, CIND was associated with lower cardiac catheterization rates (P = .002) and cardiac rehabilitation referrals (P < .001). Patients with moderate/severe CIND had higher risk-adjusted 1-year mortality that was nonstatistically significant (adjusted hazard ratio 1.97, 95% CI 0.99-3.94, P = .054; referent normal, TICS-m >22). Quality of life across cognitive status was similar at 1 year.

Conclusions

Most older patients surviving AMI have measurable CIND. Cognitive impairment without dementia was associated with less invasive care, less referral and participation in cardiac rehabilitation, and worse risk-adjusted 1-year survival in those with moderate/severe CIND, making it an important condition to consider in optimizing AMI care.

Le texte complet de cet article est disponible en PDF.

Plan


 Frans J.J. Van de Werf, MD, PhD, served as guest editor for this article.
 Others' funding sources and affiliations: Dr Gharacholou is a participant in the NIH clinical research loan repayment program (1L30 AG034828-01) and is currently at the University of Wisconsin School of Medicine and Public Health, Division of Cardiology, Madison, WI 53792.
 The TRIUMPH study was supported by grant P50 HL077113 from the National Heart, Lung, and Blood Institute Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease.


© 2011  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 162 - N° 5

P. 860 - novembre 2011 Retour au numéro
Article précédent Article précédent
  • Management of acute coronary syndromes in developing countries: ACute Coronary Events—a multinational Survey of current management Strategies
  • The ACCESS Investigators a b ?
| Article suivant Article suivant
  • Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: A double-blind, randomized trial
  • Prabowo Tunggal, Fook-Hong Ng, Kwok-Fai Lam, Francis K.L. Chan, Yuk-Kong Lau

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.